Evidence map›Paper›PMID 31118961›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

A Network Pharmacology Study on the Active Ingredients and Potential Targets of

Wei Hu, Wanjin Fu, Xin Wei, Yang Yang, Chao Lu, Zeyuan Liu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Frontiers in immunology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Article
  10. A Network Pharmacology Approach to Reveal the Underlying Mechanisms ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Study on the Multitarget Mechanism of Sanmiao Pill on Gouty Arthritis Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wei HuDepartment of Clinical Pharmacology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.
Wanjin FuDepartment of Pharmacology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-1254-5441
Xin WeiDepartment of Pharmacology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-5115-1787
Yang YangDepartment of Pharmacology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0003-1410-8963
Chao LuDepartment of Pharmacology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-7023-6129
Zeyuan LiuDepartment of Clinical Pharmacology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.ORCID 0000-0003-2663-7440
Anhui Medical University · CNAcademy of Military Medical Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicine has specific effect on some chronic diseases in clinic, especially in rheumatic diseases.

Identifiers

PMID31118961
PMCPMC6500618
OpenAlexW2935774605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.